Ditchcarbon
  • Contact
  1. Organizations
  2. MedSelect, Inc.
Public Profile
Medical Device Manufacturing
US
updated a month ago

MedSelect, Inc. Sustainability Profile

Company website

MedSelect, Inc., a leading player in the healthcare technology sector, is headquartered in the United States and operates extensively across North America. Founded in 2005, the company has established itself as a pioneer in medical supply chain management and healthcare logistics, providing innovative solutions that enhance operational efficiency for healthcare providers. MedSelect's core offerings include advanced inventory management systems and data analytics tools, designed to optimise resource allocation and reduce costs. What sets MedSelect apart is its commitment to integrating cutting-edge technology with user-friendly interfaces, ensuring seamless adoption by healthcare professionals. With a strong market position, MedSelect has garnered recognition for its contributions to improving patient care and operational workflows. The company continues to expand its footprint, striving to lead the way in transforming healthcare logistics for a more efficient future.

DitchCarbon Score

How does MedSelect, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

27

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

27

Industry Benchmark

MedSelect, Inc.'s score of 27 is lower than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.

50%

Let us know if this data was useful to you

MedSelect, Inc.'s reported carbon emissions

Inherited from Cencora, Inc.

MedSelect, Inc., headquartered in the US, currently does not report specific carbon emissions data for the latest year, as indicated by the absence of emissions figures. The company is part of a corporate family that includes Cencora, Inc., from which it inherits emissions data and climate commitments. As of now, MedSelect, Inc. has not established any documented reduction targets or climate pledges. The absence of specific initiatives or targets suggests that the company may still be in the early stages of developing its climate strategy. Given its relationship with Cencora, Inc., any future emissions data or climate commitments may be influenced by the sustainability initiatives and targets set by Cencora. This includes potential alignment with industry standards such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), which are also cascaded from Cencora, Inc. In summary, while MedSelect, Inc. currently lacks specific emissions data and reduction targets, its affiliation with Cencora, Inc. may provide a pathway for future climate commitments and performance improvements.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20192024
Scope 1
98,742,000
000,000,000
Scope 2
110,191,000
00,000,000
Scope 3
19,881,916,000
00,000,000,000

How Carbon Intensive is MedSelect, Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. MedSelect, Inc.'s primary industry is Medical, precision and optical instruments, watches and clocks (33), which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is MedSelect, Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for MedSelect, Inc. is in US, which has a low grid carbon intensity relative to other regions.

MedSelect, Inc.'s Scope 3 Categories Breakdown

MedSelect, Inc.'s Scope 3 emissions, which increased by 104% last year and increased by approximately 104% since 2019, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Downstream Transportation & Distribution" being the primary emissions source at 1% of Scope 3 emissions.

Top Scope 3 Categories

2024
Downstream Transportation & Distribution
<1%

MedSelect, Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

MedSelect, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy